355 related articles for article (PubMed ID: 22381062)
21. Structure-based virtual screening of dipeptidyl peptidase 4 inhibitors and their in vitro analysis.
Rahman SU; Ali HS; Jafari B; Zaib S; Hameed A; Al-Kahraman YMSA; Langer P; Iqbal J
Comput Biol Chem; 2021 Apr; 91():107326. PubMed ID: 32739275
[TBL] [Abstract][Full Text] [Related]
22. A comparative study of the binding modes of recently launched dipeptidyl peptidase IV inhibitors in the active site.
Nabeno M; Akahoshi F; Kishida H; Miyaguchi I; Tanaka Y; Ishii S; Kadowaki T
Biochem Biophys Res Commun; 2013 May; 434(2):191-6. PubMed ID: 23501107
[TBL] [Abstract][Full Text] [Related]
23. DPP-IV Inhibitory Phenanthridines: Ligand, Structure-Based Design and Synthesis.
Khalaf RA; Masalha D; Sabbah D
Curr Comput Aided Drug Des; 2020; 16(3):295-307. PubMed ID: 30526469
[TBL] [Abstract][Full Text] [Related]
24. Discovery of Novel DPP-IV Inhibitors as Potential Candidates for the Treatment of Type 2
Musoev A; Numonov S; You Z; Gao H
Molecules; 2019 Aug; 24(16):. PubMed ID: 31394858
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, biological assay in vitro and molecular docking studies of new imidazopyrazinone derivatives as potential dipeptidyl peptidase IV inhibitors.
Zhu Y; Xia S; Zhu M; Yi W; Cheng J; Song G; Li Z; Lu P
Eur J Med Chem; 2010 Nov; 45(11):4953-62. PubMed ID: 20800322
[TBL] [Abstract][Full Text] [Related]
26. Identification of a Novel Scaffold for Inhibition of Dipeptidyl Peptidase-4.
Mishra A; Cross M; Hofmann A; Coster MJ; Karim A; Sattar A
J Comput Biol; 2019 Dec; 26(12):1470-1486. PubMed ID: 31390221
[TBL] [Abstract][Full Text] [Related]
27. Identification of 3-aminomethyl-1,2-dihydro-4-phenyl-1-isoquinolones: a new class of potent, selective, and orally active non-peptide dipeptidyl peptidase IV inhibitors that form a unique interaction with Lys554.
Banno Y; Miyamoto Y; Sasaki M; Oi S; Asakawa T; Kataoka O; Takeuchi K; Suzuki N; Ikedo K; Kosaka T; Tsubotani S; Tani A; Funami M; Tawada M; Yamamoto Y; Aertgeerts K; Yano J; Maezaki H
Bioorg Med Chem; 2011 Aug; 19(16):4953-70. PubMed ID: 21764322
[TBL] [Abstract][Full Text] [Related]
28. Exploration of DPP-IV inhibitors with a novel scaffold by multistep in silico screening.
Uchida T; Wakasugi M; Kitamura T; Yamamoto T; Asakura M; Fujiwara R; Itoh T; Fujii H; Hirono S
J Mol Graph Model; 2018 Jan; 79():254-263. PubMed ID: 29274572
[TBL] [Abstract][Full Text] [Related]
29. Discovery of 3H-imidazo[4,5-c]quinolin-4(5H)-ones as potent and selective dipeptidyl peptidase IV (DPP-4) inhibitors.
Ikuma Y; Hochigai H; Kimura H; Nunami N; Kobayashi T; Uchiyama K; Furuta Y; Sakai M; Horiguchi M; Masui Y; Okazaki K; Sato Y; Nakahira H
Bioorg Med Chem; 2012 Oct; 20(19):5864-83. PubMed ID: 22938786
[TBL] [Abstract][Full Text] [Related]
30. Structure based virtual screening of MDPI database: discovery of structurally diverse and novel DPP-IV inhibitors.
Tanwar O; Tanwar L; Shaquiquzzaman M; Alam MM; Akhter M
Bioorg Med Chem Lett; 2014 Aug; 24(15):3447-51. PubMed ID: 24948564
[TBL] [Abstract][Full Text] [Related]
31. Combined Ligand-Based and Structure-Based Virtual Screening Approach for Identification of New Dipeptidyl Peptidase 4 Inhibitors.
Upadhyay J; Gajjar A; Suhagia BN
Curr Drug Discov Technol; 2019; 16(4):426-436. PubMed ID: 30255759
[TBL] [Abstract][Full Text] [Related]
32. Dipeptidyl peptidase IV and its inhibitors: therapeutics for type 2 diabetes and what else?
Juillerat-Jeanneret L
J Med Chem; 2014 Mar; 57(6):2197-212. PubMed ID: 24099035
[TBL] [Abstract][Full Text] [Related]
33. Discovery of triazole-based uracil derivatives bearing amide moieties as novel dipeptidyl peptidase-IV inhibitors.
Deng X; Han L; Zhou J; Zhang H; Li Q
Bioorg Chem; 2017 Dec; 75():357-367. PubMed ID: 29096096
[TBL] [Abstract][Full Text] [Related]
34. The highly potent and selective dipeptidyl peptidase IV inhibitors bearing a thienopyrimidine scaffold effectively treat type 2 diabetes.
Deng J; Peng L; Zhang G; Lan X; Li C; Chen F; Zhou Y; Lin Z; Chen L; Dai R; Xu H; Yang L; Zhang X; Hu W
Eur J Med Chem; 2011 Jan; 46(1):71-6. PubMed ID: 21106276
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and potent inhibitory activities of carboxybenzyl-substituted 8-(3-(R)-aminopiperidin-1-yl)-7-(2-chloro/cyanobenzyl)-3-methyl-3,7-dihydro-purine-2,6-diones as dipeptidyl peptidase IV (DPP-IV) inhibitors.
Mo DW; Dong S; Sun H; Chen JS; Pang JX; Xi BM; Chen WH
Bioorg Med Chem Lett; 2015 May; 25(9):1872-5. PubMed ID: 25838146
[TBL] [Abstract][Full Text] [Related]
36. New leads for DPP IV inhibition: structure-based pharmacophore mapping and virtual screening study.
Almasri IM; Taha MO; Mohammad MK
Arch Pharm Res; 2013 Nov; 36(11):1326-37. PubMed ID: 23918649
[TBL] [Abstract][Full Text] [Related]
37. Glutamic acid analogues as potent dipeptidyl peptidase IV and 8 inhibitors.
Lu IL; Lee SJ; Tsu H; Wu SY; Kao KH; Chien CH; Chang YY; Chen YS; Cheng JH; Chang CN; Chen TW; Chang SP; Chen X; Jiaang WT
Bioorg Med Chem Lett; 2005 Jul; 15(13):3271-5. PubMed ID: 15927466
[TBL] [Abstract][Full Text] [Related]
38. Design, Synthesis and Biological Evaluation of Imidazo[1,2-a]pyridine Derivatives as Novel DPP-4 Inhibitors.
Li Q; Zhou M; Han L; Cao Q; Wang X; Zhao L; Zhou J; Zhang H
Chem Biol Drug Des; 2015 Oct; 86(4):849-56. PubMed ID: 25787859
[TBL] [Abstract][Full Text] [Related]
39. Effects of Different Dietary Flavonoids on Dipeptidyl Peptidase-IV Activity and Expression: Insights into Structure-Activity Relationship.
Gao F; Fu Y; Yi J; Gao A; Jia Y; Cai S
J Agric Food Chem; 2020 Oct; 68(43):12141-12151. PubMed ID: 33063510
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and biological evaluation of triazole based uracil derivatives as novel DPP-4 inhibitors.
Li Q; Han L; Zhang B; Zhou J; Zhang H
Org Biomol Chem; 2016 Oct; 14(40):9598-9611. PubMed ID: 27714283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
